A Texas Life Science Perspective. Thomas R. Kowalski President Texas Healthcare and Bioscience Institute

Similar documents
EXECUTIVE SUMMARY Prepared for: Pharmaceutical Research and Manufacturers of America (PhRMA) Prepared by: Battelle Technology Partnership Practice

What the Public Sector Should Know about Venture Capital

The Texas Biotechnology Industry

Advocacy Resources Community

Profile of Biomedical Research and Biotechnology Commercialization. San Francisco Oakland San Jose Consolidated Metropolitan Statistical Area

TECHNOLOGY TRANSFER IN TENNESSEE

Finding Talent: Site Selection Labor Market Considerations for the Life Sciences Industry

The Role of Research Institutions in the Formation of the Biotech Cluster in Massachusetts

New Jersey Bio-Pharmaceutical Life Sciences Landscape

SAN DIEGO S CLEANTECH INDUSTRY AT A GLANCE

FORMULA FOR ILLINOIS FUTURE IN BIOSCIENCE ILLINOIS SCIENCE + TECHNOLOGY PARK. EXECUTIVE SUMMARY ADDENDUM February 2006

Profile of Biomedical Research and Biotechnology Commercialization. Boston-Worcester-Lawrence Consolidated Metropolitan Statistical Area

Vista. Although the total. South Texas Economic Trends and Issues. Biotech and the San Antonio Economy

ACC San Diego Chapter

RE AP QUE PLIC FOR IONS. Compa CPRIT RFA C 12 FORM 2. Company. p.1/17

President and CEO. Research Park Corporation. Baton Rouge, Louisiana

Russia USA Science to Innovations Accelerator (RUSSIA) Business Development and Training Program a at Arizona State University

BENCHMARKING OF BUSINESS INCUBATORS. in the Republic of Moldova. Aurelia Braguta

U.S. Metro Area Economies

OVERVIEW & ECONOMIC IMPACT OF RESEARCH PARKS. Greg Hyer, Associate Director University Research Park University of Wisconsin Madison

Silicon Valley s Competition Creating a Technopolis

Achievement of Korea s Healthcare Industry. Devices. World s largest market share in ultrasound imaging devices ( 14) Competitiveness

Rising Concentration in Agricultural Input Industries Influences New Farm Technologies

Biotechnology Management

Why Atlanta For Your Business?

Life Sciences Outlook. San Diego 2015

E113- Shared Accounting Finance Impact Department, BSA

Is Canada Ready to Play in the Big Leagues in Attracting Investment?

New York City Economic Development Corporation Lenzie Harcum, Bioscience Desk November, 2009

Emerging Clinical Sites: India and China. Patrycja Doba, Clinical Research Coordinator

A BIOMEDICAL CLUSTER 15 years in the making. October 9, 2015

RECOMMEND APPROVAL OF MASTER OF SCIENCE IN BIOMEDICAL SCIENCE AND BIOTECHNOLOGY AT UNIVERSITY OF COLORADO DENVER

Recruitment Strategies to Attract the BEST Faculty

Corporate Prospectus January 2015

The Virginia Bioscience Economy Initiative A roadmap to significant new and lasting economic growth, jobs and private investment Building on and

2012 Data Center Reports. Incentives

Richard T. Clark Chief Executive Officer and President. Executing on Our Strategy

The Cluster Initiative Zurich Mednet Swiss Biotechnology Virtual and Real Market Platforms

Building Regional Innovation Capacity: The San Diego Experience

The Economic Impact of the Biotechnology and Pharmaceutical Industries in New York

DIVERSIFIED LEADER IN HEALTHCARE STAFFING & OUTSOURCING

Technology Business Tax Certificate Transfer Program (NOL)

Compliance and the Cloud. Guiding principles and architecture for addressing Life Science compliance in the cloud

Profile of Biomedical Research and Biotechnology Commercialization. Philadelphia Wilmington Atlantic City Consolidated Metropolitan Statistical Area

FINANCIALLY SUSTAINABLE INCUBATION MODELS KEY SUCCESS FACTORS WG3 TIERS OF SUPPORT

Introduction. The Healthcare Sector in Asia - Current Situation. Projected Healthcare Expenditure

U.S. Contract Research Outsourcing Market: Trends, Challenges and Competition in the New Decade. N8B7-52 December 2010

Professional Science Masters Degrees. What are PSM degrees?

Pennino Corporation TECHNOLOGY TO IMPROVE LIFE

COMMONWEALTH FUND LLC 2550 Dogwood Drive Youngstown, Ohio Telephone (650)

Biotechnology in North Carolina

The Role of Government in Supporting Entrepreneurship & SME Development

Profile of Biomedical Research and Biotechnology Commercialization. Washington-Baltimore Consolidated Metropolitan Statistical Area

BIOTECHNOLOGY. Bouvé College of Health Sciences College of Science. Networked for Success. Networked for Industry. Networked for Life.

INVITATION LETTER ASSIGNMENT TITLE: INDIVIDUAL CONSULTANCY SERVICES RELATED TO THE TRAINING ON ADVANCED GCP TRAINING FOR RBC/MRC.

Venture Impact. The Economic Importance of Venture Capital to the Texas Economy. Jon Bayless, General Partner

BIOSCIENCE 08 OKLAHOMA. Recent State Initiatives

MediSapiens Ltd. Bio-IT solutions for improving cancer patient care. Because data is not knowledge. 19th of March 2015

Irene Spanos Director Economic Development & Community Affairs Oakland County, Michigan

Regulatory Affairs Graduate & Postgraduate Program. Novartis Pharma AG Novartis Animal Health AG

The agency perspective: What we do and how we do it

Providing High-Quality Innovation and Technology Support Services University Experience and Best Practices. Professor Stanley Kowalski

2012 Public Policy Priorities A pro-growth, pro-jobs agenda for New York

Profile of Biomedical Research and Biotechnology Commercialization. San Diego Metropolitan Statistical Area

Battelle PMP Public Affairs Consulting, Inc BIO Biotechnology Industry Organization

Innovation in San Diego s Past, Present and Future?

1. I appreciate the opportunity to make remarks to the UC Regents today.

Establishing Local Capital Markets. Access to capital fosters innovation

Candidate Campaign Website and Contact Information (optional):

CLEMSON UNIVERSITY OFFICE OF ECONOMIC DEVELOPMENT

Business Information for R&D and Strategic Planning

Gian Luca Sacco Marketing Director South & Central Europe. Smarter decisions, better products.

Best Practices for Launching Tech Ventures and Leveraging the University Mission Funding Strategies

SECTION A. TECHNICAL NOTES

Rutgers Mini-MBA : BioPharma Entrepreneurship

Increasing Patient Access through Oral Parity Legislation

How To Become A Scientist

Rutgers Mini-MBA : BioPharma Innovation

A Competitive Advantage Assessment and Strategy for Nebraska. EXECUTIVE SUMMARY Growing Jobs, Industries, and Talent:

HOMELAND SECURITY MARKET DEVELOPMENT IN ILLINOIS

CAREER & TECHNICAL EDUCATION

Dear Business Development or Corporate Alliance Director/Manager,

Arizona and PSMs. Collaboration Across Arizona Universities for a Better Arizona

Income Statement Format and Disclosures 2007 Conference call for Financial Analysts, November 2007 Ian Bishop

Bayer Invests Heavily in R&D and is committed to innovation Sustained Innovation Output from all Subgroups

OPEN INNOVATION STRATEGIES IN THE HEALTHCARE INDUSTRY

pharmaceutical & biotechnology

Best Practices for Launching Tech Ventures and Leveraging the University Mission Accelerating New Ventures

An Action Plan to Grow Colorado s Bioscience Cluster

NORTH CAROLINA STATE UNIVERSITY NORTH CAROLINA STATE UNIVERSITY Office of Technology Transfer

Multitude of opportunities for Finnish pharmaceutical industry in India

CALIFORNIA STATE UNIVERSITY CHANNEL ISLANDS

10,050 SQ. FT. BUILDING FOR SALE IN SO. TEXAS MEDICAL CTR.

Energizing Wisconsin s Economy

BUILDING A STRONGER SOCIETY SOCIAL IMPACT INVESTMENT February 2014 Submission in response to the Discussion Paper

Benchmarking the Rhode Island Knowledge Economy

The Geography of Markets for Technology: Evidence from Bio- Pharmaceuticals

Areas where STATISTICS are used. Government Census, Law, National Defense

MEMORANDUM. Members of the Interim Committee on Economic Development

The Leukemia & Lymphoma Society A powerhouse among nonprofits searching for cancer cures

Transcription:

A Texas Life Science Perspective Thomas R. Kowalski President Texas Healthcare and Bioscience Institute 1

What is THBI? The Texas Healthcare and Bioscience Institute (THBI) is a non-profit, public policy research organization, comprised of biotechnology, medical device, and pharmaceutical companies, economic development entities, academic, and private research institutions, as well as companies that provide goods and services to core organizations. 2

THBI Mission Statement The mission of the Texas Healthcare and Bioscience Institute is to research, develop, and advocate policies and actions that promote biomedical science, biotechnology, agriculture, and medical device innovation in Texas. 3

Defining the Biosciences The biosciences are a diverse group of industries and activities with a common link-they apply knowledge of the way in which plants, animals, and humans function. The sector spans different markets and includes manufacturing, services, and research activities. By definition, the biosciences are a unique industry cluster and are constantly growing and changing to incorporate the latest research and scientific discoveries. Source: BIO 4

The Life Science Innovation Lifecycle Knowledge Creation Universities and Research Institutions Federal R&D Regulatory Environment Licenses Patents Proof of Concept Testing Conception Incubation/ Research Parks Formation Venture Capital Clinical Trials Technology Transfer Collaborations/ Partnerships Regulatory Approval Industry Consortia And Partnerships Maturity Growth Business Planning Industry R&D Job Creation M&A Activity IPOs/Gazelles Product Pipeline Clusters and Networks Economics of Scale Value-add Labor Market/ Graduates Commercialization 5

Key Best Practice Factors in Building a Biosciencedriven Economy Ingredients for building a critical mass in the biosciences in states and regions include: n Engaged universities with active leadership n Building entrepreneurial cultures with intensive networking across sectors and with industry n Available capital covering all stages of business cycle n Discretionary federal or other R&D funding n Workforce and talent pool n Access to specialized facilities and equipment n Supportive business, tax and regulatory policies n Patience and a long-term perspective 6

7

Texas Legislative Sessions Texas Emerging Technology Fund (79 th ) Has allocated $194 million in funds to 136 early stage companies Has allocated over $194 million in grant matching and research superiority funds to Texas Universities $592 Million in additional follow-on investments Texas Enterprise Fund (78 th ) The TEF has awarded $98.1million for biotechnology related projects, creating 11,451 jobs Pharmaceutical Biotech Cleanroom Exemption (80 th ) Texas Cancer Prevention and Research Institute of Texas (80 th ) $3B - $300MM per year for 10 years/to date, 429 awards worth $760 MM for cancer research, commercialization and prevention Texas Tier One Initiative $500MM Product Development Fund $45 MM 8

Texas Enterprise Fund 9

10

Emerging Technology Fund 11

Texas Regional Centers of Innovation and Commercialization 12

Economic Impact of Life Sciences on Texas The Life Sciences industry generates a significant economic impact on the state of Texas, as companies and institutions purchase equipment and inputs and well paid employees spend money in their home communities. The industry s total economic impact on the State of Texas is estimated at $75 billion in economic activity, 236,000 jobs, and $31 billion in payroll. State and local governments receive an estimated $2 billion each year due to these impacts. 13

Direct and Indirect Impacts of Life Sciences in Texas 14

Texas Healthcare and Bioscience Institute 815 Brazos Street Suite 310 Austin, Texas 78701 512 708 8424 512 708 1607 www.thbi.com 15